Latest Shareholder Approvals News

Altitude Minerals is gearing up for significant drilling campaigns in New South Wales and Nevada, backed by a recent $1.15 million capital raise to fund exploration and project advancement.

Opthea Limited resumes ASX trading as it pivots to develop OPT-302 for lymphangioleiomyomatosis, outlining a disciplined 18-month staged clinical program backed by A$31.2 million in cash.

Tivan Limited has locked in a minimum $15 million funding package through a $10 million option underwriting agreement and a $5 million share placement with strategic investor ETFS Capital, supporting accelerated development across its Australian and Timor-Leste projects.

Stavely Minerals has issued its Tranche 2 placement shares following shareholder approval, with key investors increasing stakes. The company eyes a mid-year scoping study and imminent diamond drilling at promising copper-gold-silver and gold prospects.

Group 6 Metals disclosed breaches of ASX Listing Rule 10.1 due to related party transactions made without required shareholder approval during a period of negative equity. The company will seek retrospective approval at a July meeting and has since returned to positive equity.

Bio-Gene Technology has expanded its capital raise to $2.775 million through a share placement priced at 2.5 cents, attaching options exercisable at 3.5 cents pending shareholder approval.

Desert Metals Limited has raised $1 million through a placement at a 2.9% premium, backing exploration at its Scotty Lithium and Monger Gold projects alongside new growth opportunities.

St George Mining has restructured its Lithium Star joint venture, with battery giant Amperex Technology Limited exchanging its 10% JV stake for a 12.5 million shareholding in St George at a 36% premium. This move consolidates lithium exploration under St George while giving ATL exposure to the Araxá niobium-rare earths project and offtake rights on future lithium production.

Green Cross Health plans to sell its Medical division, The Doctors, for NZ$270 million to Tend Health, refocusing on its pharmacy business. Completion hinges on shareholder approval expected by July 2026.

Heartland Group Holdings has agreed to acquire TSB Bank for NZD 620 million, merging the two into a challenger bank with $18 billion in assets and expected 20% EPS accretion.

Strata Minerals has secured a binding agreement with BML Ventures to fund and manage mining at its Zelica Gold Project, paving a capital-light path to production and profit sharing.

Bounty Oil & Gas NL has locked in A$4.5 million from a heavily oversubscribed share placement, with proceeds earmarked for drilling, facility upgrades, and exploration across its Australian assets.